These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 3737296)
41. The frequency of PKU and hyperphenylalaninemia in Sweden - a study in institutions for the mentally retarded as well as in neonates. Holmgren G; Larsson A; Palmstierna H; Alm J Clin Genet; 1976 Dec; 10(6):313-8. PubMed ID: 991440 [TBL] [Abstract][Full Text] [Related]
42. Phenylketonuria and hyperphenylalaninemia in eastern Germany: a characteristic molecular profile and 15 novel mutations. Hennermann JB; Vetter B; Wolf C; Windt E; Bührdel P; Seidel J; Mönch E; Kulozik AE Hum Mutat; 2000; 15(3):254-60. PubMed ID: 10679941 [TBL] [Abstract][Full Text] [Related]
43. Prevention of fetal damage through dietary control of maternal hyperphenylalaninemia. Ghavami M; Levy HL; Erbe RW Clin Obstet Gynecol; 1986 Sep; 29(3):580-5. PubMed ID: 3757336 [TBL] [Abstract][Full Text] [Related]
44. Hyperphenylalaninemia in a premature infant with heterozygosity for phenylketonuria. Hennermann JB; Loui A; Weber A; Mönch E J Perinat Med; 2004; 32(4):383-5. PubMed ID: 15346830 [TBL] [Abstract][Full Text] [Related]
45. Phenylketonuria and its variants: observations on intellectual functioning. Netley C; Hanley WB; Rudner HL Can Med Assoc J; 1984 Oct; 131(7):751-5. PubMed ID: 6478363 [TBL] [Abstract][Full Text] [Related]
46. Experience with hyperphenylalaninemia in a developing country: unusual clinical manifestations and a novel gene mutation. Karam PE; Daher RT; Moller LB; Mikati MA J Child Neurol; 2011 Feb; 26(2):142-6. PubMed ID: 20823030 [TBL] [Abstract][Full Text] [Related]
51. Autism and phenylketonuria. Baieli S; Pavone L; Meli C; Fiumara A; Coleman M J Autism Dev Disord; 2003 Apr; 33(2):201-4. PubMed ID: 12757360 [TBL] [Abstract][Full Text] [Related]
52. The New England Maternal PKU Project: identification of at-risk women. Waisbren SE; Doherty LB; Bailey IV; Rohr FJ; Levy HL Am J Public Health; 1988 Jul; 78(7):789-92. PubMed ID: 3381953 [TBL] [Abstract][Full Text] [Related]
53. Malignant hyperphenylalaninemia: CT and MR of the brain. Brismar J; Aqeel A; Gascon G; Ozand P AJNR Am J Neuroradiol; 1990; 11(1):135-8. PubMed ID: 2105595 [TBL] [Abstract][Full Text] [Related]
54. Heterozygote advantage for the phenylketonuria allele. Saugstad LF J Med Genet; 1977 Feb; 14(1):20-4. PubMed ID: 839495 [TBL] [Abstract][Full Text] [Related]
55. Three cases of untreated classical PKU: a report on cataracts and brain calcification. Kawashima H; Kawano M; Masaki A; Sato T Am J Med Genet; 1988 Jan; 29(1):89-93. PubMed ID: 3344778 [TBL] [Abstract][Full Text] [Related]
56. Frequency of phenylketonuria in Norway. Saugstad LF Clin Genet; 1975 Jan; 7(1):40-51. PubMed ID: 1116309 [TBL] [Abstract][Full Text] [Related]
57. Gestational carrier--a reproductive haven for offspring of mothers with phenylketonuria (PKU): an alternative therapy for maternal PKU. Fisch RO; Tagatz G; Stassart JP J Inherit Metab Dis; 1993; 16(6):957-61. PubMed ID: 8127071 [TBL] [Abstract][Full Text] [Related]
58. Assessment of parents´ knowledge regarding phenylketonuria and its affecting factors: a cross-sectional study. Öztürk FÜ; Bülbül SF; Alpcan A Pan Afr Med J; 2022; 41():308. PubMed ID: 35855041 [TBL] [Abstract][Full Text] [Related]
59. A clinical epidemiologic study of hyperphenylalaninemia. Wrona RM Am J Public Health; 1979 Jul; 69(7):673-9. PubMed ID: 453394 [TBL] [Abstract][Full Text] [Related]